Distributor inventory | Tablet
Glimepiride 2 mg + Metformin hydrochloride 500 mg (immediate-release)
Type 2 diabetes mellitus in adults when diet and exercise alone or monotherapy is insufficient; helps control blood glucose and HbA1c.
Glimepiride (a sulfonylurea) stimulates the pancreas to release insulin and improves insulin sensitivity. Metformin (a biguanide) reduces glucose production in the liver and improves peripheral glucose uptake, lowering blood sugar without usually causing hypoglycaemia on its own.
Oral tablet. Take exactly as prescribed, usually once or twice daily with meals to reduce stomach upset. Swallow whole with water; do not skip meals. Monitor blood glucose regularly.
Common side effects of ZORYL MS IR 2/500MG TAB may include:
Risk of hypoglycaemia (higher with missed meals, alcohol, heavy exercise, elderly, kidney/liver impairment). Metformin rarely can cause lactic acidosis—seek urgent care for fast breathing, severe weakness, abdominal pain, or unusual sleepiness. Use with caution/avoid in severe renal impairment, severe hepatic disease, dehydration, severe infection, shock, or hypoxia; temporarily stop before/after iodinated contrast or major surgery as advised. Check kidney function periodically; long-term metformin may cause vitamin B12 deficiency. Not for type 1 diabetes or diabetic ketoacidosis.
